31 related articles for article (PubMed ID: 8045522)
1. The pathologic diagnosis of mantle cell lymphoma.
Li S; Xu J; You MJ
Histol Histopathol; 2021 Oct; 36(10):1037-1051. PubMed ID: 34114641
[TBL] [Abstract][Full Text] [Related]
2. De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly.
Elyamany G; Alzahrani AM; Al Mussaed E; Aljasem H; Alotaibi S; Elghezal H
Case Rep Hematol; 2015; 2015():146598. PubMed ID: 26347832
[TBL] [Abstract][Full Text] [Related]
3. Potential effects of CRM1 inhibition in mantle cell lymphoma.
Zhang KJ; Wang M
Chin J Cancer Res; 2012 Dec; 24(4):374-87. PubMed ID: 23357869
[TBL] [Abstract][Full Text] [Related]
4. Blastoid variant of mantle cell lymphoma with lactic acidosis: a case report.
Ohtsubo K; Imamura R; Seki R; Ohshima K; Hashiguchi M; Yakushiji K; Yoshimoto K; Ogata H; Okamura T; Sata M
Int J Hematol; 2004 Dec; 80(5):428-31. PubMed ID: 15646654
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas.
Aguilera NS; Bijwaard KE; Duncan B; Krafft AE; Chu WS; Abbondanzo SL; Lichy JH; Taubenberger JK
Am J Pathol; 1998 Dec; 153(6):1969-76. PubMed ID: 9846986
[TBL] [Abstract][Full Text] [Related]
6. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor.
Quintanilla-Martinez L; Thieblemont C; Fend F; Kumar S; Pinyol M; Campo E; Jaffe ES; Raffeld M
Am J Pathol; 1998 Jul; 153(1):175-82. PubMed ID: 9665478
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology of low grade malignant lymphomas.
Ratech H
Med Oncol; 1995 Sep; 12(3):167-76. PubMed ID: 8852399
[TBL] [Abstract][Full Text] [Related]
8. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
Griesser DH
Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
[TBL] [Abstract][Full Text] [Related]
9. Mantle cell lymphoma: an update.
Raffeld M; Sander CA; Yano T; Jaffe ES
Leuk Lymphoma; 1992 Oct; 8(3):161-6. PubMed ID: 1490145
[TBL] [Abstract][Full Text] [Related]
10. The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices.
Ott MM; Ott G; Kuse R; Porowski P; Gunzer U; Feller AC; Müller-Hermelink HK
Histopathology; 1994 Apr; 24(4):329-34. PubMed ID: 8045522
[TBL] [Abstract][Full Text] [Related]
11. Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma.
Williams ME; Swerdlow SH; Rosenberg CL; Arnold A
Cancer Res; 1992 Oct; 52(19 Suppl):5541s-5544s. PubMed ID: 1394169
[TBL] [Abstract][Full Text] [Related]
12. Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus.
Williams ME; Westermann CD; Swerdlow SH
Blood; 1990 Oct; 76(7):1387-91. PubMed ID: 2207314
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.
Williams ME; Swerdlow SH; Rosenberg CL; Arnold A
Leukemia; 1993 Feb; 7(2):241-5. PubMed ID: 8426477
[TBL] [Abstract][Full Text] [Related]
14. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes.
Williams ME; Meeker TC; Swerdlow SH
Blood; 1991 Jul; 78(2):493-8. PubMed ID: 2070085
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 protein in centrocytic lymphoma; a paraffin section study.
Swerdlow SH; Utz GL; Williams ME
Leukemia; 1993 Sep; 7(9):1456-8. PubMed ID: 8371594
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]